Appeal has no power
Originally produced for LexisNexis, Chris Thomas recounts the reasoning behind the judge’s support of the Hearing Officer in a judgment handed down on 11 April 2019.
Read more
Synthetic Biology: Fuelling the Growth of the Bioeconomy
Parminder Lally discusses the commonality between AI, software, 5G and IoT innovations as highlighted at SynbiTECH 2019 and this year’s Cambridge Wireless International Conference.
Read more
Big Data, Big Problem?
Parminder Lally looks at the issues that in-house attorneys may need to consider when dealing with AI.
Read more Key Points: computing Inventions in Europe
Ian Robinson provides an important update on patent eligibility in Europe for computing-related inventions, including the latest announcements for Artificial Intelligence (AI) and Machine Learning (ML).
Read more Can artificial intelligence match human intelligence?
Julia Gwilt and Parminder Lally attended the Cambridge Wireless event on "Narrowing the Intelligence Gap", hosted at Amazon's site in Cambridge. The event featured an excellent talk by Neil Lawrence (IPC Machine Learning at Amazon and Professor of Machine Learning at the University of Sheffield) on whether the latest AI is "more human".
Read more PCT Direct – Fast forward to positive PCT outcomes
Ithel Jones examines the value of using the PCT Direct service offered by the European Patent Office.
Read more Problematic Priorities
In the last few months, the European Patent Office has decided that the priority claim of a number of pending patent applications and granted patents was invalid. In this article, Parminder Lally looks at the reasons behind these decisions and the consequences, and provides tips on how to avoid priority issues on your own patent applications.
Read more Further uncertainty for biotech/agritech patent applicants
Are products exclusively obtained by essentially biological processes patentable at the EPO?
Read more
Patenting Mobile Apps
Richard Bray and Samuel Bird discuss the patentability of mobile apps.
Read more Eli Lilly v Genentech
Eli Lilly v Genentech: the question of SPCs based on third party MAs is referred to the CJEU.
Read more
Patentability of products obtained from biological processes
After years of controversy, the Technical Board of Appeal (TBA) of the EPO has recently decided that products obtained by essentially biological processes can be patent protected (T1063/18).
Read more
